Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preventing Oxidative Stress-induced Ischemic Injury- and Systemic Inflammation Complications During and After Invasive Cardiac Surgery With Alkaline Phosphatase (APPIRED III)

NCT03050476 is registered in ClinicalTrials.gov with Alloksys Life Sciences B.V. as lead sponsor.

NCT NCT03050476
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03050476 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preventing Oxidative Stress-induced Ischemic Injury- and Systemic Inflammation Complications During and After Invasive Cardiac Surgery With Alkaline Phosphatase (APPIRED III)
Lead sponsor
Alloksys Life Sciences B.V.
Phase
Phase 2/3
Overall status
Unknown status
Start date
November 1, 2017
Completion date
March 31, 2026
Enrollment
1,250 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

cardiopulmonary-bypass, systemic inflammation